CELL POPULATIONS WHICH CO-EXPRESS CD49C AND CD90

WIPO Patent Application WO2003025149

A8

Substantially homogenous cells populations which co-express CD49c, CD90 and telomerase are made. In one embodiment, humans suffering from a degenerative, traumatic, acute injury, cardiac or neurological condition are treated with the substantially homogenous cells populations which co-express CD49c, CD90 and telomerase. In another embodiment, committed progenitor cells are made are made by selecting from a cultured source of a cell populations which co-express CD49c and CD90 and modifying the cell population. The committed progenitor cells can be employed to treat a human suffering from a degenerative, traumatic, acute injury, cardiac or neurological condition and to formulate pharmaceutical compositions. In a further embodiment, a substantially homogenous populaton of cells which co-express CD49c, CD90 and at least one cardiac-related transcription factor is made and can be used to treat a human suffering from a cardiac condition.

JP2024502629	Synbiotic treatment regimen
WO/2000/074729	ALPHA OR BETA EMITTERS TO FRAGMENTS IN RADIOIMMUNOTHERAPY
JP3070865	Description: Subset of human progenitor cells

HO TONY W (US)
KOPEN GENE C (US)
RIGHTER WILLIAM F (US)
RUTKOWSKI J LYNN (US)
HERRING W JOSEPH (US)
RAGAGLIA VANESSA (US)
WAGNER JOSEPH (US)

PCT/US2002/029971

August 19, 2004

September 20, 2002

Click for automatic bibliography generation  

NEURONYX INC (US)
HO TONY W (US)
KOPEN GENE C (US)
RIGHTER WILLIAM F (US)
RUTKOWSKI J LYNN (US)
HERRING W JOSEPH (US)
RAGAGLIA VANESSA (US)
WAGNER JOSEPH (US)

A61K35/28; C12N15/09; A61K35/34; A61K35/36; A61K35/44; A61K35/50; A61P9/04; A61P9/10; A61P19/08; A61P21/04; A61P25/00; A61P25/16; A61P35/00; C12N5/0775; C12N5/0797; A61K35/12; (IPC1-7): C12N5/06; C12N5/08

View/Download PDF      PDF Help

Previous Patent: NOVEL NUCLEIC ACIDS AND POLYPEPTIDES

Next Patent: LIPID-ASSOCIATED MOLECULES